Risks of emergency use authorizations for medical products during outbreak situations: a COVID-19 case study.
PMID: 33008462 ·
A, l, m, i, r, , B, a, d, n, j, e, v, i, ć, ;, , L, e, j, l, a, , G, u, r, b, e, t, a, , P, o, k, v, i, ć, ;, , Z, i, j, a, d, , D, ž, e, m, i, ć, ;, , F, a, h, i, r, , B, e, č, i, ć
Реклама
Аннотация
The world is facing an unprecedented outbreak affecting all aspects of human lives which is caused by the COVID-19 pandemic. Due to the virus novelty, healthcare systems are challenged by a high rate of patients and the shortage of medical products. To address an increased need for essential medical products, national authorities, worldwide, made various legislative concessions. This has led to essential medical products being produced by automotive, textile and other companies from various indu
Реклама
Официальный источник
Открыть в PubMed →Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.